Back to Search
Start Over
Partial restoration of GH responsiveness to ghrelin in Cushing's disease after 6 months of ketoconazole treatment: comparison with GHRP-6 and GHRH
- Source :
- Repositório Institucional da UNIFESP, Universidade Federal de São Paulo (UNIFESP), instacron:UNIFESP
- Publication Year :
- 2009
- Publisher :
- Oxford University Press (OUP), 2009.
-
Abstract
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Objective: in Cushing's disease (CD), GH responsiveness to several stimuli, including ghrelin, GHRP-6, and GHRH. is blunted. Recovery of GH secretion after remission of hypercortisolism after transsphenoidal surgery. radiotherapy or adrenalectomy is controversial. There are no studies evaluating the effect of primary clinical treatment with ketoconazole on GH secretion in CD. the aim of this study is to compare ghrelin-, GHRP-6-, and GHRH-induced GH release before and after ketoconazole in MDesign: GH responses to ghrelin. GHRP-6, and GHRH of eight untreated patients with CD (mean age: 33.8 +/- 3.1 years; body mass index: 28.5 +/- 0.8 kg/m(2)) were evaluated before and after 3 and 6 months of ketoconazole treatment. and compared with I I controls (32.1 +/-.2.5: 25.0 +/- 0.8).Methods: Serum GH was measured by an immunofluorometric assay and urinary free cortisol (UFC) by liquid chromatography and tandem mass spectrometry.Results: After ketoconazole use, mean UFC decreased significantly (before: 222.4 +/- 35.0 mu g/24 h: third month: 61.6 +/-+10.1: sixth month: 39.1 +/- 10.9). Ghrelin-induced GH secretion increased significantly after 6 months (peak before: 6.8 +/- 2.3 mu g/l: sixth month: 16.0 +/- 3.6). but remained lower than that of controls (54.1 +/- 11.2). GH release after GHRP-6 increased, although not significantly. while GH responsiveness to GHRH Was unchanged.Conclusions: Ghrelin-induced GH release increases significantly after 6 months of ketoconazole treatment in CD. This could suggest that, it decrease in cortisol levels during this time period can partially restore glucocorticoid-induced GH suppression in CD. GH-releasing mechanisms stimulated by ghrelin/GHS could be more sensitive, as no changes in GHRH-induced GH release were observed. Universidade Federal de São Paulo, Div Endocrinol, BR-04039002 São Paulo, Brazil Inst Fleury, BR-04344903 São Paulo, Brazil Universidade Federal de São Paulo, Div Endocrinol, BR-04039002 São Paulo, Brazil FAPESP: 02/14118-9 Web of Science
- Subjects :
- Adult
Male
medicine.medical_specialty
Hydrocortisone
Endocrinology, Diabetes and Metabolism
medicine.medical_treatment
Growth Hormone-Releasing Hormone
Statistics, Nonparametric
Young Adult
Cushing syndrome
chemistry.chemical_compound
Endocrinology
Internal medicine
medicine
Humans
GHRP-6
Insulin-Like Growth Factor I
Pituitary ACTH Hypersecretion
Human Growth Hormone
business.industry
Adrenalectomy
General Medicine
Cushing's disease
medicine.disease
Ghrelin
Growth hormone secretion
Ketoconazole
chemistry
Area Under Curve
Female
business
Oligopeptides
medicine.drug
Subjects
Details
- ISSN :
- 1479683X and 08044643
- Volume :
- 161
- Database :
- OpenAIRE
- Journal :
- European Journal of Endocrinology
- Accession number :
- edsair.doi.dedup.....b65d1bb592befa3f635b30d11165d0b8
- Full Text :
- https://doi.org/10.1530/eje-09-0459